Which component of an enzyme binds to the substrate?

A. do not cause many human infections: While some fungi, protozoa, and helminths cause fewer infections compared to bacteria, the main limitation in drug development is not the frequency of infections. Even common infections like candidiasis or malaria require treatment, so infection prevalence alone does not explain the scarcity of effective drugs.

B. have fewer target sites compared to bacteria: These organisms do possess cellular structures that could be targeted, such as cell membranes, enzymes, or nucleic acids. The issue is not the number of potential targets but the similarity of those targets to human cells, which complicates drug design.

C. are so similar to human cells that selective drug toxicity is difficult to achieve: Fungi, protozoa, and helminths are eukaryotic, like human cells, meaning their cellular structures and metabolic pathways closely resemble those of the host. This similarity makes it challenging to develop drugs that are toxic to the pathogen but safe for human cells, limiting the number of available therapeutic options.

D. are parasites found inside human cells: While intracellular parasites pose delivery challenges for drugs, this is not the primary reason for the overall scarcity of antifungal, antiprotozoan, and antihelminth medications. Drug development is limited mainly by eukaryotic similarity rather than intracellular location alone.

E. are not affected by antimicrobics: This is incorrect because antifungal, antiprotozoan, and antihelminth drugs do exist and can be effective. The challenge is creating agents that selectively target these organisms without harming human cells, not an inherent resistance to all antimicrobial agents.

A. Hydrogen bonds: Hydrogen bonds hold complementary nitrogenous bases together between the two strands of the DNA double helix. Adenine pairs with thymine through two hydrogen bonds, while guanine pairs with cytosine through three hydrogen bonds. These relatively weak bonds allow the DNA strands to separate easily during replication and transcription while still maintaining overall structural stability of the molecule.

B. Sulfhydryl bonds: Sulfhydryl bonds (also known as disulfide bonds) occur between sulfur-containing amino acids such as cysteine in proteins. These bonds help stabilize the tertiary and quaternary structures of proteins. They are not involved in the bonding between DNA bases.

C. Nonpolar covalent bonds: Nonpolar covalent bonds involve equal sharing of electrons between atoms with similar electronegativities. While covalent bonds are important within molecules, the interactions between complementary DNA bases are not nonpolar covalent bonds. Instead, base pairing specifically relies on hydrogen bonding.

D. Peptide bonds: Peptide bonds are covalent bonds that link amino acids together to form polypeptide chains in proteins. They are fundamental to protein structure and are formed during protein synthesis on ribosomes. DNA molecules do not contain peptide bonds because they are composed of nucleotides rather than amino acids.

E. Polar covalent bonds: Polar covalent bonds occur when electrons are shared unequally between atoms with different electronegativities, creating partial charges within a molecule. While polar covalent bonds exist within individual DNA molecules, they do not hold the complementary base pairs together between the two strands.